| 000 | 01496 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250517025330.0 | ||
| 264 | 0 | _c20160115 | |
| 008 | 201601s 0 0 eng d | ||
| 022 | _a1554-8937 | ||
| 024 | 7 |
_a10.1021/acschembio.5b00240 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBenjamin, Daniel I | |
| 245 | 0 | 0 |
_aDiacylglycerol Metabolism and Signaling Is a Driving Force Underlying FASN Inhibitor Sensitivity in Cancer Cells. _h[electronic resource] |
| 260 |
_bACS chemical biology _cJul 2015 |
||
| 300 |
_a1616-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aDiglycerides _xmetabolism |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aFatty Acid Synthases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aGlucose _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aProtein Kinase C _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aLi, Daniel S | |
| 700 | 1 | _aLowe, Wallace | |
| 700 | 1 | _aHeuer, Timothy | |
| 700 | 1 | _aKemble, George | |
| 700 | 1 | _aNomura, Daniel K | |
| 773 | 0 |
_tACS chemical biology _gvol. 10 _gno. 7 _gp. 1616-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/acschembio.5b00240 _zAvailable from publisher's website |
| 999 |
_c24802405 _d24802405 |
||